12 NEWS


DSM-Firmenich hails FDA proposal as win for consumers


DSM-Firmenich has hailed the US Food and Drug Administration’s proposal to approve its Parsol Shield UV filter as an active ingredient in sunscreens as a victory for consumers. The Swiss-Dutch company


anticipates that the FDA will issue a final order by June 2026, after which Parsol Shield would benefit from an 18-month exclusivity in the US market as sponsor of the Tier 1 OTC Monograph Order Request (OMOR). On 11 December, the FDA said it


would approve bemotrizinol – the USAN nonproprietary name for the UV filter - at concentrations up to six per cent in over the counter (OTC) sunscreens. The filter is an oil-soluble organic


compound that provides low-level skin absorption and provides broad spectrum protection to absorb UV rays, absorbing both UVB and UVA rays.


The proposed filter has already


been approved in Europe since 2000. If approved by the FDA,


bemotrizinol would become the first new sunscreen active ingredient added to the US OTC sunscreen monograph since 1999. It would be the third sunscreen


active ingredient - in addition to zinc oxide and titanium dioxide - to be generally recognized as safe and effective for use by adults and children six months of age and older.


CPL Aromas cuts Shanghai hub ribbon


British fragrance house CPL Aromas has opened a new office and fine fragrance centre of excellence in Shanghai, China. The company said the new


facilities would position it closer to customers, ensuring faster, more agile, and more tailored fragrance solutions. “Investing in these facilities,


CPL Aromas will be able to deliver the highest standards of product quality, innovation, and service to customers across China,” said a spokeswoman. “Shanghai was chosen as


DSM-Firmenich said, if finalized,


this milestone would expand consumer choice, strength public health, and advance the fight against skin cancer across the US. “This is an incredible win for


American public health and skin cancer prevention! The FDA’s proposal is a major milestone for American consumers and our brand partners,” added Carl D’Ruiz, senior business development manager, Beauty & Care North America. Dr. Jochen Klock, Director, Global


Regulatory Affairs Beauty & Care, added: “Parsol Shield is designed to deliver broad-spectrum UVB/ UVA performance even at low levels, helping protect against sun induced skin damage, skin cancer


and premature photoaging—with aesthetics consumers love and global formulation chassis potential for faster, simpler launches.” Meanwhile, the American


Academy of Dermatology Association said the addition of bemotrizinol to the list of permitted sunscreen ingredients would greatly benefit US public health. “The Academy hopes this


proposed sunscreen filter is an indicator that the FDA is poised to move forward with lagging approvals of innovative and new sunscreen ingredients – many of which are available to consumers abroad – that will help save the lives of Americans from skin cancer,” it added.


Seppic gets fresh with marine ingredient trio


French cosmetic ingredient maker Seppic has unveiled new efficacy data for three marine actives: Phlorogine, Aspar’Age and Celtosome Eryngium Maritimum. The in vivo and in vitro data


strengthen the evidence for the ingredients’ targeted action on skin mechanisms linked to three major current trends: skin purity, longevity, and aesthetic procedure alternatives. Phlorogine CV, an extract of


Laminaria saccharina, has its purifying efficacy confirmed by new in vivo data validating a triple action: sebum level is reduced by 29.3%, visible imperfections decrease by 10.8%, and complexion radiance is revived by +20.3%.


crow’s feet by nearly twice as much as the placebo. Efficacy is visible: the skin


appears significantly younger, less tired (77%), and more uniform (68%). Thirdly, Celtosome Eryngium


Targeting deep longevity mechanisms to meet ‘well- aging’ expectations, Aspar’Age (Asparagopsis armata) confirms its in vivo action against ‘contagious aging’ by protecting young fibroblasts from the SMS (senescence messaging secretome) emitted by senescent fibroblasts. At 2%, it reduces the length of


PERSONAL CARE MAGAZINE February 2026


Maritimum was confirmed as a gentle alternative to hyaluronic acid injections. While in vitro tests already


demonstrate an increase in hyaluronic acid production of +103% and a strengthening of Collagen I (+28%) and Elastin (+34%), the clinical study reveals a smoothing effect. After 28 days, wrinkle surface


area is reduced by 12%. The active also offers immediate hydration superior to the placebo.


www.personalcaremagazine.com


the home of this new centre for its unique ability to balance heritage with modernity, a city where tradition meets cutting- edge technology and global innovation, will be the origin and inspiration of many new creations and exciting projects,” she added. A highlight of the


inauguration event was said to be the presentation of Morphesis, CPL Aromas’ annual Global Macrotrend collection that was first unveiled in Barcelona in June and continued its journey in Shanghai. Morphesis is a fusion of


two concepts: Metamorphosis, symbolising radical change, and Genesis, representing origin. The collection is built around


five elemental concepts: The Egg, The Seed, The Chrysalis, The Amber and The Atom. In addition to Morphesis,


CPL Aromas presented a new and highly anticipated technology, representing a breakthrough innovation that will soon be launched officially. This technology “promises


to redefine the perfumery experience and marks a significant before and after” moment for the industry, the spokeswoman said.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72